2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$141.68+$0.67 (+0.47%)
Price as of Jul 31, 2026 7:34 PM EDT- $6.9BMarket Cap
- 18.59%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$141.68+$0.67 (+0.47%)
RGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $141.01 | ||
Change | -$2.59 (-1.80%) | ||
Open | $143.81 | ||
High | $145.00 | ||
Low | $139.40 | ||
Previous Close | $143.60 | ||
Volume | 875,270 | ||
30-Day Average Volume | 1,202,050 | ||
1-Week Change | 6.86% | ||
1-Month Change | 3.35% | ||
1-Year Change | 18.59% | ||
3-Year Change | -17.81% | ||
5-Year Change | -42.61% | ||
Fundamentals | |||
Shares Outstanding | 48.9M | ||
Total Assets | $3.0B | ||
Market Cap | $6.9B | ||
Enterprise Value | $6.8B | ||
Period: QTR TTM FY | |||
Revenue | $204.1M | ||
Net Income | $5.0M | ||
Free Cash Flow | $27.4M | ||
EBIT | $20.1M | ||
EBITDA | $39.2M | ||
Net Working Capital | $1.1B | ||
EPS | $0.09 | ||
Enterprise Value/EBITDA | 175 | ||
Enterprise Value/Revenue | 34 | ||
P/B | 3 | ||
P/E | 1,567 | ||
PEG | -39 | ||
Price/Free Cash Flow | 251 | ||
Price/Operating Cash Flow | 211 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue